Identification | Back Directory | [Name]
IDX-184 | [CAS]
1036915-08-8 | [Synonyms]
IDX-184 2'-C-Methylguanosine 5'-[2-[(3-hydroxy-2,2-dimethyl-1-oxopropyl)thio]ethyl N-(phenylmethyl)phosphoramidate] Guanosine, 2'-C-methyl-, 5'-[2-[(3-hydroxy-2,2-dimethyl-1-oxopropyl)thio]ethyl N-(phenylmethyl)phosphoramidate] | [Molecular Formula]
C25H35N6O9PS | [MDL Number]
MFCD23381633 | [MOL File]
1036915-08-8.mol | [Molecular Weight]
626.62 |
Hazard Information | Back Directory | [Uses]
IDX184 is a potent and orally bioavailable inhibitor of HCV replication. IDX184 potently inhibits HCV polymerase (IC50=0.31 μM, Ki=52.3 nM)[1][2]. | [References]
[1] Xiao-Jian Zhou , et al. Safety and Pharmacokinetics of IDX184, a Liver-Targeted Nucleotide Polymerase Inhibitor of Hepatitis C Virus, in Healthy Subjects. Antimicrob Agents Chemother. 2011 Jan;55(1):76-81. DOI:10.1128/AAC.01101-10 [2] IN VITRO ANTIVIRAL ACTIVITY AND PHARMACOLOGY OF IDX184, A NOVEL AND POTENT INHIBITOR OF HCV REPLICATION. |
|
Company Name: |
AstaTech, Inc
|
Tel: |
(215) 785 3197 |
Website: |
www.astatechinc.com |
|